BONUS EPISODE: Pandemic Perspectives with John Maraganore
About this episode
Our senior producer, Mariel Carr, talks with John Maraganore, the CEO of Alnylam Pharmaceuticals, a company developing an antiviral medication for COVID-19.
When news broke in January about the new coronavirus, John Maraganore made the decision to pause other drugs in development and pivot to working on an antiviral medication for this new and alarmingly infectious virus.
He says it was a difficult decision, but this virus had all the ingredients to become a pandemic. "And when you have a public health crisis like this, that's what you do."
Get every episode summarized
Each time Distillations | Science History Institute publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Distillations | Science History Institute
Agnes Pockels and the Kitchen Sink Myth
Distillations | Science History Institute
Flemmie Kittrell and the Preschool Experiment
Distillations | Science History Institute
The CRISPR Babies
Distillations | Science History Institute
Humans and Monsters: An Interview with Surekha Davies
Distillations | Science History Institute